Linco-Spectin 50 mg/100 mg injekčný roztok
Linco-Spectin 50 mg/100 mg injekčný roztok
Authorised
- Streptomycin sulfate
- Lincomycin hydrochloride
Product identification
Medicine name:
Linco-Spectin 50 mg/100 mg injekčný roztok
Active substance:
- Streptomycin sulfate
- Lincomycin hydrochloride
Target species:
-
Pig
-
Cattle (newborn calf)
-
Sheep
-
Dog
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Streptomycin sulfate250.60/milligram(s)1.00millilitre(s)
-
Lincomycin hydrochloride54.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal14day
-
-
Cattle (newborn calf)
-
Meat and offal21day
-
-
Sheep
-
Meat and offal15day
-
Milk0dayDo not use in sheep whose milk is intended for human consumption.
-
-
Dog
-
Not applicable0dayNot applicable
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Available in:
-
Slovakia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Ceska Republika s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 99/148/87-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Slovak (PDF)
Published on: 1/09/2025